Study guide
12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
Key Takeaways Explain This Topic AI
Objective extubation criteria require a quantitative train-of-four (TOF) ratio ≥0.90 at the adductor pollicis; qualitative assessments (e.g., 5-second head lift) fail to rule out significant residual neuromuscular block.
Key respiratory extubation thresholds include Negative Inspiratory Force (NIF) more negative than -25 to -30 cmH₂O, Vital Capacity >10-15 mL/kg, spontaneous tidal volume >5-8 mL/kg, and SpO₂ >95% on FiO₂ ≤0.40.
Awake extubation is mandatory in difficult airways, full stomachs, and severe OSA, whereas deep extubation (Stage III, Plane 2-3 with regular respiration and TOF ≥0.90) avoids coughing and hemodynamic surges in reactive airway disease and ocular/vascular surgeries. Extubation during Stage II (Excitement Stage) is strictly contraindicated.
Laryngospasm involves afferent sensory input via the internal branch of the superior laryngeal nerve and efferent motor spasm of intrinsic adductors via the recurrent laryngeal nerve; treatment begins with 100% O₂, Larson's notch pressure, and 20-30 cmH₂O CPAP, advancing to Propofol (0.5 mg/kg) or Succinylcholine (0.1-0.5 mg/kg IV).
Negative Pressure Pulmonary Edema (NPPE) occurs when vigorous inspiratory efforts against a closed glottis generate extreme negative intrathoracic pressure (-50 to -100 cmH₂O), precipitating transudative alveolar flooding; primary management is CPAP/PEEP (5-10 cmH₂O) and supplemental oxygen.
Last updated: August 2026
12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
Emergence and tracheal extubation represent one of the most hazardous phases of general anesthesia, accounting for a significant proportion of perioperative respiratory complications. Systematic evaluation of neuromuscular recovery, airway reflexes, and ventilatory mechanics is essential. The CRNA must master the differential indications for awake versus deep extubation, execute rapid crisis management for acute laryngospasm, and recognize post-obstructive negative pressure pulmonary edema (NPPE).
1. Objective Readiness Criteria for Tracheal Extubation
Extubation should only proceed when the patient satisfies comprehensive neuromuscular, ventilatory, gas-exchange, and neurological readiness criteria. +-------------------------------------------------------------------------+
- | OBJECTIVE EXTUBATION CRITERIA |
- +-----------------------+-------------------------------------------------+
- | Clinical Category | Mandatory Quantitative & Clinical Thresholds |
- +-----------------------+-------------------------------------------------+
- | **Neuromuscular | • Quantitative Train-of-Four (TOF) ratio ≥ 0.90 |
- | Recovery** | (measured at adductor pollicis muscle) |
- | | • No visual or tactile fade on double burst |
- | **Ventilatory | • Negative Inspiratory Force (NIF) < -25 to |
- | Mechanics** | -30 cmH₂O (maximum inspiratory effort) |
- | | • Vital Capacity (VC) > 10 - 15 mL/kg |
- | | • Spontaneous Tidal Volume (VT) > 5 - 8 mL/kg |
- | | • Respiratory Rate: 10 - 30 breaths/min |
- | | • Rapid Shallow Breathing Index (RSBI) < 105 |
- | **Gas Exchange & | • SpO₂ > 95% on FiO₂ ≤ 0.40 (or PaO₂ > 60 mmHg) |
- | Oxygenation** | • PaCO₂ < 45 - 50 mmHg with normal pH (≥ 7.35) |
- | | • PaO₂ / FiO₂ ratio > 200 - 300 |
- | **Airway Protection & | • Return of swallowing, gag, and cough reflexes |
- | Neurologic State** | • Purposeful response to commands (eye opening, |
- | | hand grip, head lift) |
- | **Systemic Factors** | • Core temperature ≥ 36.0°C; normotensive; no |
- | | significant acid-base or electrolyte derangement|
- +-----------------------+-------------------------------------------------+
- Why Clinical Tests Alone Are Dangerous
Historical clinical signs of reversal—such as a 5-second sustained head lift, tongue protrusion, or sustained hand grip—can be successfully performed when the TOF ratio is as low as 0.60 − 0.70 0.60 - 0.70 0.60 − 0.70 . At this level of residual block:
Pharyngeal constrictor muscles remain weak, permitting upper airway collapse.
The vocal cord adductor-abductor coordination is impaired.
The hypoxic ventilatory drive is blunted by up to 30 − 50 % 30 - 50\% 30 − 50% .
Aspiration risk is dramatically elevated.
Mandate: Quantitative neuromuscular monitoring demonstrating a TOF ratio ≥ 0.90 \ge 0.90 ≥ 0.90 ( ≥ 90 % \ge 90\% ≥ 90% ) at the adductor pollicis is required prior to extubation.
2. Awake vs. Deep Extubation: Indications, Techniques & The Stage II Trap +-------------------------------------------------------------------------+
- | AWAKE vs DEEP EXTUBATION COMPARISON |
- +--------------------+------------------------+---------------------------+
- | Feature | Awake Extubation | Deep Extubation |
- +--------------------+------------------------+---------------------------+
- | **Anesthetic | Fully awake; follows | Stage III, Plane 2-3 |
- | Depth** | commands; intact cough | (Deep surgical plane) |
- | **Breathing** | Regular, spontaneous; | Regular, spontaneous, |
- | | robust tidal volume | unhurried breathing |
- | **Neuromuscular** | TOF ratio ≥ 0.90 | TOF ratio ≥ 0.90 |
- | Status** | (Fully reversed) | (Fully reversed) |
- | **Eye Position** | Central, open, focused | Central, miotic, conjugate|
- | **Indications** | • Difficult airway | • Reactive airway disease |
- | | • Aspiration / GERD | (Asthma, severe COPD) |
- | | • Morbid obesity / OSA | • Avoid wound strain: |
- | | • Prone/sitting surgery| hernia, thyroidectomy, |
- | | • Unstable spine/facial| tympanoplasty, vascular |
- | | trauma | • Avoid IOP / ICP surges |
- | **Advantages** | Intact airway reflexes;| Suppresses coughing, |
- | | lower aspiration risk | bucking, and hemodynamics |
- | **Disadvantages** | Coughing, bucking, | Risk of airway obstruction|
- | | hypertension, tachycardia, laryngospasm, and |
- | | raised ICP, IOP, CVP | silent aspiration |
- +--------------------+------------------------+---------------------------+
- Guedel's Stages of Anesthesia & The Stage II Trap [GUEDEL'S STAGES DURING EMERGENCE]
- STAGE III (Surgical Plane) --> STAGE II (Excitement Stage) --> STAGE I (Awake)
- Regular breathing • IRREGULAR BREATHING • Regular breathing
- Eyes central/miotic • DIVERGENT / NYSTAGMIC EYES • Eyes open/focused
- No response to suction • HYPERREFLEXIC AIRWAY • Follows commands
- DEEP EXTUBATION ZONE • DANGER ZONE (NEVER EXTUBATE!) • AWAKE EXTUBATION ZONE
NCE Board Warning — Stage II Extubation: Extubating a patient during Guedel Stage II (Excitement Stage) is strictly CONTRAINDICATED. In Stage II, cortical suppression is incomplete while subcortical centers are disinhibited. The patient exhibits irregular respirations, breath-holding, disconjugate or divergent gaze, and extreme laryngeal hyperreactivity. Any stimulus (such as ETT movement, pharyngeal secretions, or cuff deflation) will trigger catastrophic, intractable laryngospasm and severe bronchospasm .
3. Laryngospasm: Neuroanatomy, Pathophysiology & Triggers
Laryngospasm is a sustained, involuntary protective spasm of the intrinsic laryngeal adductor musculature that completely or partially seals the glottic aperture. [LARYNGOSPASM NEURAL REFLEX ARC]
- Sensory Stimulus (Blood, Secretions, ETT, Light Anesthesia)
- |
- v
- [AFFERENT SENSORY LIMB]: Internal Branch of the
- SUPERIOR LARYNGEAL NERVE (SLN)
- |
- v
- [MEDULLARY INTEGRATION CENTER]
- |
- v
- [EFFERENT MOTOR LIMB]: RECURRENT LARYNGEAL NERVE (RLN)
- |
- v
- [EFFECTOR MUSCLES]: Lateral Cricoarytenoid, Transverse Arytenoid, &
- Thyroarytenoid Muscles (Adduct True & False Vocal Cords)
- Clinical Presentation
Partial Laryngospasm: High-pitched, inspiratory stridor with diminished capnography amplitude and falling S p O 2 SpO_2 Sp O 2 .
Complete Laryngospasm: "Silent chest" with complete absence of breath sounds or air movement, flatline capnogram, and paradoxical "see-saw" thoracoabdominal motion (the chest collapses inward while the abdomen protrudes outward during desperate diaphragmatic contractions against an obstructed glottis).
4. Stepwise Emergency Protocol for Laryngospasm Management +-------------------------------------------------------------------------+
- | STEP-BY-STEP LARYNGOSPASM MANAGEMENT PROTOCOL |
- +-------------------------------------------------------------------------+
- | |
- | STEP 1: Halt Stimulation & Deliver 100% O₂ |
- | • Stop surgical stimulation immediately |
- | • Apply tight-fitting mask with 100% FiO₂ |
- | • Clear oral secretions GENTLY (avoid stimulating vocal cords) |
- | |
- | STEP 2: Larson's Maneuver & 20-30 cmH₂O CPAP |
- | • Apply firm bilateral pressure in the laryngospasm notch (behind |
- | ramus of mandible, anterior to mastoid process) |
- | • Close APL valve and apply continuous positive airway pressure |
- | (CPAP) of 20 - 30 cmH₂O to splint the glottis open |
- | |
- | STEP 3: Pharmacologic Deepening |
- | • Administer Propofol 0.5 mg/kg IV (0.25 - 0.8 mg/kg IV) |
- | • Relaxes laryngeal musculature without causing apnea |
- | |
- | STEP 4: Neuromuscular Blockade (Definitive Pharmacotherapy) |
- | • Succinylcholine 0.1 - 0.5 mg/kg IV (low sub-paralytic dose breaks |
- | spasm while preserving spontaneous ventilation) |
- | • OR Full intubating dose Succinylcholine 1.0 - 1.5 mg/kg IV |
- | • IF NO IV ACCESS: Succinylcholine 3 - 4 mg/kg IM (deltoid or tongue) |
- | • IN PEDIATRICS: Co-administer Atropine 0.02 mg/kg IV (min 0.1 mg) |
- | to prevent severe succinylcholine-induced vagal bradycardia/asystole|
- | |
- | STEP 5: Tracheal Intubation |
- | • If hypoxemia persists or cardiac arrest is imminent, re-intubate |
- +-------------------------------------------------------------------------+
- The Larson Maneuver (Laryngospasm Notch Pressure)
Anatomical Boundaries: The notch bounded anteriorly by the posterior border of the mandibular ramus, posteriorly by the mastoid process of the temporal bone, and superiorly by the skull base.
Physiology: Vigorous cephalad and anterior pressure applied bilaterally into this notch stimulates the styloid process and cranial nerve VII / glossopharyngeal sensory afferents, causing deep periosteal pain that reflexively overrides intrinsic laryngeal adductor hypertonicity while simultaneously thrusting the mandible anteriorly.
5. Negative Pressure Pulmonary Edema (NPPE / Type I POPE)
Negative Pressure Pulmonary Edema (also called Post-Obstructive Pulmonary Edema, POPE Type I) is a life-threatening form of noncardiogenic pulmonary edema that develops following acute, severe upper airway obstruction. [NPPE PATHOPHYSIOLOGIC CASCADE]
- Acute Severe Airway Obstruction (Laryngospasm, Biting ETT)
- |
- v
- Vigorous Spontaneous Inspiratory Effort (Müller Maneuver)
- |
- v
- Massive Negative Intrathoracic Pressure Generated (-50 to -100 cmH₂O)
- / \
- / \
- v v
- [Massive Increase in Transcapillary [Hyperadrenergic Surge]
- Hydrostatic Gradient (Pc - Pi)] • SVR and PVR increase
- | • Increased RV / LV Afterload
- v • Pulmonary Capillary Engorgement
- [Alveolar-Capillary Membrane Stress Failure] |
- \ /
- \-----------------------+-----------------------/
- |
- v
- [Massive Transudation of Fluid into Alveoli]
- |
- v
- Pink, Frothy Sputum, Acute Hypoxemia, Bilateral Infiltrates
- Clinical Presentation & Risk Demographics
Classic Demographic: Young, athletic, muscular males whose robust diaphragmatic strength can generate extreme negative intrathoracic pressures ( down to − 50 to − 100 cmH 2 O -50 \text{ to } -100 \text{ cmH}_2\text{O} − 50 to − 100 cmH 2 O ; normal inspiratory pressure is − 2 to − 5 cmH 2 O -2 \text{ to } -5 \text{ cmH}_2\text{O} − 2 to − 5 cmH 2 O ).
Onset: Occurs immediately or within 1 − 2 hours 1 - 2 \text{ hours} 1 − 2 hours of airway obstruction (e.g., laryngospasm, biting the ETT during emergence, foreign body).
Signs: Agitation, tachypnea, severe hypoxemia ( S p O 2 < 80 % SpO_2 < 80\% Sp O 2 < 80% ), diffuse bilateral rales, and copious pink, frothy pulmonary secretions bubbling from the airway.
Management & Treatment Protocol
Relieve Airway Obstruction & Re-establish Patency: Ensure open airway via jaw thrust, ETT bite block removal, or reintubation if needed.
Positive Pressure Ventilation & Supplemental O 2 O_2 O 2 : Apply Continuous Positive Airway Pressure ( CPAP ) or Positive End-Expiratory Pressure ( PEEP ) of 5 − 10 cmH 2 O 5 - 10 \text{ cmH}_2\text{O} 5 − 10 cmH 2 O with 100 % FiO 2 100\% \text{ FiO}_2 100% FiO 2 . Positive intra-alveolar pressure opposes transcapillary fluid transudation and recruits collapsed, fluid-filled alveoli.
Diuretic Therapy Consideration: Unlike cardiogenic pulmonary edema, NPPE is a hydrostatic gradient disruption across intact/stressed membranes rather than systemic hypervolemia. Diuretics (Furosemide 10 − 20 mg 10 - 20 \text{ mg} 10 − 20 mg IV) are usually not required unless true fluid overload exists; with CPAP/PEEP, NPPE typically resolves completely within 12 − 24 hours 12 - 24 \text{ hours} 12 − 24 hours .